Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01634958
Recruitment Status : Completed
First Posted : July 6, 2012
Last Update Posted : November 19, 2013
Information provided by (Responsible Party):
Leti Pharma GmbH

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2013
  Actual Study Completion Date : June 2013